Synergy CHC Corp. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent
Synergy CHC Corp. (SNYR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent of 3.00% for the 12-month period ending 2019-12-31, per its 10-K filed 2020-04-29.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization · last filed 2020-04-29
- Synergy CHC Corp. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2019 was 3.00%.
- Synergy CHC Corp. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2018 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent 12 month |
|---|---|
| 2019-12-31 | 3.00% 10-K · filed 2020-04-29 |
| 2018-12-31 | 0.00% 10-K · filed 2020-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |